nobiletin has been researched along with Obesity in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 8 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Butcher, JT; Fulton, DJ; Larion, S; Mintz, JD; Padgett, CA; Stepp, DW | 1 |
| Ding, W; He, Y; Pang, Y; Yang, N; Zhang, L; Zheng, Y | 1 |
| Du, C; Guo, J; Xu, Y; Zhao, C | 1 |
| Dhawan, S; Kiperman, T; Lee, J; Li, W; Ma, K; Xiong, X; Yechoor, V | 1 |
| Cao, Y; Feng, K; Ho, CT; Huang, Q; Kan, Q; Xiao, J; Xin, Y; Yin, B; Zhang, M | 1 |
| Matveyenko, AV; Rakshit, K | 1 |
| Chen, H; Cui, Z; Hu, Y; Kou, G; Li, P; Lyu, Q; Nyantakyiwaa Amoah, A; Seydou Traore, S | 1 |
| Ho, CT; Huang, Q; Li, D; Ma, YY; Zhang, M; Zhang, X; Zhao, DG; Zhu, J | 1 |
| Choi, MS; Jeong, MJ; Jung, UJ; Kim, SR; Kim, YJ; Woo, JT | 1 |
| Holland, LJ; Jackson, DE; Manthey, JA; Nichols, LA; Shukla, SD | 1 |
| Kadota, A; Kanda, K; Liu, MC; Nishi, K; Nishimoto, S; Sugahara, T | 1 |
| Cha, BY; Choi, BK; Choi, SS; Lee, YS; Nagai, K; Teruya, T; Woo, JT; Yonezawa, T | 1 |
12 other study(ies) available for nobiletin and Obesity
| Article | Year |
|---|---|
The biological clock enhancer nobiletin ameliorates steatosis in genetically obese mice by restoring aberrant hepatic circadian rhythm.
Topics: Animals; Circadian Clocks; Circadian Rhythm; Insulins; Lipids; Luciferases; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Period Circadian Proteins; RNA, Messenger; Tumor Necrosis Factor-alpha | 2022 |
Nobiletin protects enteric nerves and ameliorates disordered bowel motility in diet-induced obese mice via increasing Trem2 expression.
Topics: Animals; bcl-2-Associated X Protein; Diet, High-Fat; Gastrointestinal Motility; Inflammation; Interleukin-10; Interleukin-6; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Receptors, Immunologic; Tumor Necrosis Factor-alpha | 2022 |
Modulation of Fat Deposition-Gut Interactions in Obese Mice by Administrating with Nobiletin.
Topics: Animals; Bacteroidetes; Humans; Lipids; Mice; Mice, Obese; Obesity; RNA, Ribosomal, 16S | 2023 |
The Clock-modulatory Activity of Nobiletin Suppresses Adipogenesis Via Wnt Signaling.
Topics: Adipogenesis; Animals; Cell Differentiation; Mice; Obesity; Wnt Signaling Pathway | 2023 |
Comparative Analyses of Bioavailability, Biotransformation, and Excretion of Nobiletin in Lean and Obese Rats.
Topics: Animals; Biological Availability; Biotransformation; Citrus; Feces; Flavones; Gastrointestinal Microbiome; Humans; Male; Obesity; Plant Extracts; Rats; Rats, Sprague-Dawley | 2020 |
Induction of Core Circadian Clock Transcription Factor Bmal1 Enhances β-Cell Function and Protects Against Obesity-Induced Glucose Intolerance.
Topics: Animals; ARNTL Transcription Factors; Blood Glucose; Circadian Clocks; Circadian Rhythm; Flavones; Glucose; Glucose Intolerance; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Mice, Transgenic; Motor Activity; Obesity | 2021 |
Nobiletin activates thermogenesis of brown and white adipose tissue in high-fat diet-fed C57BL/6 mice by shaping the gut microbiota.
Topics: Acetates; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Antioxidants; Diet, High-Fat; Flavones; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Obesity; Thermogenesis | 2021 |
Bidirectional interaction of nobiletin and gut microbiota in mice fed with a high-fat diet.
Topics: Animals; Anti-Obesity Agents; Bacteria; Biotransformation; Brain; Demethylation; Diet, High-Fat; Fatty Acids, Volatile; Feces; Flavones; Gastrointestinal Microbiome; Liver; Male; Mice; Mice, Inbred C57BL; Obesity | 2021 |
Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity.
Topics: Adipose Tissue; Animals; Body Weight; Cytokines; Diet, High-Fat; Dietary Supplements; Dyslipidemias; Flavones; Hepatitis; Insulin Resistance; Lipids; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity | 2017 |
Citrus flavonoids repress the mRNA for stearoyl-CoA desaturase, a key enzyme in lipid synthesis and obesity control, in rat primary hepatocytes.
Topics: Animals; Citrus; Enzyme Repression; Flavones; Gene Expression Regulation, Enzymologic; Hepatocytes; Hesperidin; Lipids; Liver; Male; Obesity; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stearoyl-CoA Desaturase | 2011 |
Nobiletin suppresses adipocyte differentiation of 3T3-L1 cells by an insulin and IBMX mixture induction.
Topics: 1-Methyl-3-isobutylxanthine; 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Antioxidants; Cell Differentiation; Cell Line; Cyclic AMP Response Element-Binding Protein; Dexamethasone; Down-Regulation; Flavones; Gene Expression; Glucocorticoids; Insulin; Mice; Obesity; Phosphodiesterase Inhibitors; Phosphorylation; PPAR gamma; Signal Transduction; STAT5 Transcription Factor | 2012 |
Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice.
Topics: Adipokines; Adiponectin; Adipose Tissue, White; Animals; Diet, High-Fat; Eating; Flavones; Gene Expression Regulation; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Size; PPAR gamma; Triglycerides; Weight Gain | 2013 |